SARS-CoV-2 infection can activate innate and adaptive immune responses and result in exacerbated inflammatory responses, including eosinopenia and lymphopenia, with severe reduction in the frequency of CD4+ and CD8+ T cells, B cells and natural killer (NK) cells. The gene discussed is CD4; the disease is lymphopenia.